89BIO INC's ticker is ETNB and the CUSIP is 282559103. A total of 70 filers reported holding 89BIO INC in Q1 2022. The put-call ratio across all filers is 0.12 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,634,370 | -73.1% | 105,853 | -66.9% | 0.00% | -66.7% |
| Q2 2023 | $6,066,842 | +23479.8% | 320,150 | -81.0% | 0.00% | -78.6% |
| Q1 2023 | $25,729 | +29.9% | 1,689,347 | +8.6% | 0.01% | +27.3% |
| Q4 2022 | $19,811 | -99.6% | 1,556,233 | +83.2% | 0.01% | +266.7% |
| Q3 2022 | $4,919,000 | +924.8% | 849,547 | +469.7% | 0.00% | – |
| Q2 2022 | $480,000 | +86.8% | 149,122 | +118.6% | 0.00% | – |
| Q1 2022 | $257,000 | -89.6% | 68,217 | -34.4% | 0.00% | -100.0% |
| Q1 2021 | $2,463,000 | -11.1% | 104,013 | -8.5% | 0.00% | 0.0% |
| Q4 2020 | $2,771,000 | -8.9% | 113,699 | -4.1% | 0.00% | -50.0% |
| Q3 2020 | $3,042,000 | +602.5% | 118,543 | +446.2% | 0.00% | +300.0% |
| Q2 2020 | $433,000 | – | 21,703 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Orchard Capital Management, LLC | 551,879 | $7,025,420 | 2.36% |
| RA Capital Management | 8,955,410 | $114,002,369 | 2.31% |
| Cormorant Asset Management, LP | 2,550,000 | $32,462 | 2.17% |
| Deep Track Capital, LP | 3,850,000 | $49,010,500 | 2.06% |
| COMMODORE CAPITAL LP | 758,244 | $9,652 | 1.46% |
| Ikarian Capital, LLC | 454,000 | $5,779,419 | 1.39% |
| DAFNA Capital Management LLC | 324,173 | $4,126,722 | 1.16% |
| Parkman Healthcare Partners LLC | 332,880 | $4,237,562 | 1.13% |
| Boxer Capital, LLC | 1,400,000 | $17,822,000 | 0.94% |
| Orbimed Advisors | 3,658,869 | $46,577,402 | 0.89% |